Russell S. Miller

Russell S. Miller

Auto-generated profile, based on publicly available information

Russell S. Miller

Division of Maternal Fetal Medicine Columbia University Irving Medical Center New York New York USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2015 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
LTLea Tuzovic
Lea Tuzovic
STSha Tang
Sha Tang
RMRussell S. Miller
Russell S. Miller
LRLuis Rohena
Luis Rohena
LSLayla Shahmirzadi
Layla Shahmirzadi
KAKwame Anyane-Yeboa
Kwame Anyane-Yeboa
Objective: To identify the molecular basis for prenatally suspected cases of megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) (MIM 249210) in 3 independent families with clinical and radiographic evidence of MMIHS. Methods: Whole-exome sequencing (WES) and Sanger sequencing of the ACTG2 gene. Results: We identified a novel heterozygous de novo missense variant in ACTG2 c.770G>A (p.Arg257His) encoding γ-2 smooth muscle actin (ACTG2) in 2 siblings with MMIHS, suggesting gonadal mosaicism of one of the parents. Two additional de novo missense variants (p.Arg257Cys and p.Arg178His) in ACTG2 were identified in 2 additional MMHIS patients. All of our patients had evidence of fetal megacystis and a normal or slightly increased amniotic fluid volume. Additional findings included bilateral renal hydronephrosis, an enlarged fetal stomach, and transient dilated bowel loops. ACTG2 immunostaining of the intestinal tissue showed an altered muscularis propria, a markedly thinned longitudinal muscle layer, and a reduced amount and abnormal distribution of ACTG2. Conclusion: Our study demonstrates that de novo mutations in ACTG2 are a cause of fetal megacystis in MMIHS and that gonadal mosaicism may be present in a subset of cases. These findings have implications for the counseling of families with a diagnosis of fetal megacystis with a preserved amniotic fluid volume and associated gastrointestinal findings.

21 February 2014 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
LTLea Tuzovic
Lea Tuzovic
KAKwame Anyane-Yeboa
Kwame Anyane-Yeboa
AMAshley Mills
Ashley Mills
KGKenneth Glassberg
Kenneth Glassberg
RMRussell Miller
Russell Miller
Objective: To investigate prenatal ultrasonographic findings associated with megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS). Methods: A PubMed search was performed using the terms ‘MMIHS', ‘MMIH' and ‘prenatal diagnosis'. Results: A total of 50 cases were analyzed. Prenatal diagnosis was achieved in 26% of cases. In 54% of patients with a correct antenatal diagnosis there was a previously affected sibling. Fetal megacystis with or without hydroureteronephrosis was the most common initial ultrasonographic finding (88%). While megacystis eventually complicated all fetal presentations, isolated bilateral hydronephrosis and isolated dilated stomach were noted (in 10 and 2% of cases, respectively) prior to megacystis. The initial sonographic abnormality was most commonly detected (in 70% of patients) in the second trimester. Amniotic fluid was normal in 69% and increased in 27% of cases. Gastrointestinal abnormalities were noted in 24% of pregnancies. Conclusion: MMIHS should be prenatally suspected when fetal megacystis is associated with a normal or increased amount of amniotic fluid and normal external genitalia, especially in the setting of a suggestive family history. Associated gastrointestinal findings support this diagnosis. Isolated bilateral hydronephrosis may precede the development of megacystis. Due to preserved renal function and a general absence of oligohydramnios, no rationale exists for vesicoamniotic shunt placement.

30 July 2024 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
PDF file
NBNoelle Breslin
Noelle Breslin
TJTaylor Jacob
Taylor Jacob
CBCaitlin Baptiste
Caitlin Baptiste
JTJaqueline Thompson
Jaqueline Thompson
CCCheng Chen
Cheng Chen
RMRussell Miller
Russell Miller
Introduction: Limited data exist regarding outcomes when pre- and periviable PPROM (PPROM ≤26 weeks of gestation) occurs as a complication of fetoscopic laser surgery (FLS) for twin-twin transfusion syndrome (TTTS). Methods: This is a retrospective cohort study of FLS cases performed at a single institution between January 2015 and May 2021. Study inclusion was limited to patients with monochorionic-diamniotic twin pregnancies complicated by TTTS who underwent FLS. Patients were grouped by pPPROM status, and further stratified to those continuing with expectant management, and outcomes were compared between groups. The primary outcome was survival to live birth of at least one twin. Results: During the study period, 171 patients underwent FLS and a total of 96 (56.1%) subjects satisfied inclusion criteria. Among included subjects, 18 (18.8%) experienced pPPROM after FLS and 78 (81.2%) did not. Baseline characteristics were similar between groups. Among patients with pPPROM, 11 (61.1%) pursued expectant management and 7 (38.9%) opted for pregnancy termination. Among expectantly managed subjects, median pPPROM-to-delivery interval was 47.0 days (6.0–66.0 IQR) with a median gestational age at delivery of 29+1 weeks (24 + 4–33 + 6 IQR). Rates of survival to live birth of at least one twin (90.9% vs. 96.2% p = 0.42) were similar between those with pPPROM undergoing expectant management and those without pPPROM. Dual survivorship (45.5% vs. 78.2%, p = 0.03), perinatal survival to live birth (68.2% vs. 87.2%, p = 0.05), and perinatal survival to newborn hospital discharge (59.1% vs. 85.9%, p = <0.01) were all significantly lower among those with pPPROM. Gestational age at delivery was lower among those continuing with pregnancies complicated by pPPROM (29 + 1 vs. 32+5 weeks, p = <0.01). Conclusion: Survival of at least one twin to live birth remained high among those pursing expectant management after experiencing post-FLS pPPROM, suggesting that the outlook after this complication is not necessarily poor. However, this complication was associated with lower chances of dual survival and greater prematurity.

11 August 2026 in Pregnancy
Verified
Journal Article
Open access
PDF file
TKThomas P. Kishkovich
Thomas P. Kishkovich
GTGabriela F. Tessler
Gabriela F. Tessler
MAMeghan Angley
Meghan Angley
YZYijia Zhang
Yijia Zhang
TIThomas A. Imahiyerobo
Thomas A. Imahiyerobo
RWRonald Wapner
Ronald Wapner
Introduction: Cleft lip and palate (CLP) are common congenital disruptions of the orofacial cleft and are associated with numerous genetic conditions. This study examines prenatal findings, clinical outcomes, and genetic findings among prenatally diagnosed CLP, with a focus on the yield of next‐generation sequencing (NGS). Methods: This was a retrospective cohort study of prenatally diagnosed CLP presenting to a tertiary‐care referral center between 2017 and 2024. Inclusion required pre‐/postnatal diagnostic genetic testing. Imaging findings, genetic diagnoses, and delivery and postnatal outcomes were compared between those with isolated CLP (iCLP) and CLP with additional anomalies (CLP+). t ‐tests, Wilcoxon rank‐sum test, chi‐square test, or Fisher's exact test were used as appropriate. Results: A total of 57 pregnancies met inclusion criteria: 19 (33.3%) iCLP and 38 (66.7%) CLP+. Among CLP+, the most common additional prenatally detected anomalies were central nervous system (55.3%) and cardiac (52.6%). Groups had similar rates of termination and live birth (26.0% and 68.0% overall, respectively). Neonatal intensive care unit (NICU) admission was frequent at 70.6%, and similar between groups (50.0% iCLP vs. 81.8% CLP+, p = 0.11). Across the cohort, 21 (36.8%) pregnancies had reported findings from genetic testing, with 16 (28.1% of total cohort, 76.2% of those with genetic findings) possessing findings explanatory of CLP. CLP+ pregnancies were more likely to have explanatory genetic findings (36.8% vs. 10.5%, p = 0.04). Eleven of 16 (68.8%) likely causative findings were detected via karyotype/CMA. Among 29 patients with NGS, five (17.2%) had likely causative variants not detected by karyotype/CMA. NGS increased overall pathogenic diagnostic yield from 19.3% to 28.1% and diagnosed additional clinically relevant findings in three cases. Conclusion: Postnatal outcomes were overall similar between groups, with high rates of NICU admission. While CLP+ had higher rates of genetic findings, all CLP had risk of genetic disorders. In cases with non‐causative karyotype/CMA, sequencing revealed explanatory diagnostic variants in one in six cases, increasing diagnostic yield by nearly 10%. We advocate for comprehensive prenatal imaging and diagnostic genetic evaluation, including sequencing, for all prenatal CLP cases.

15 December 2015 in Fetal Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
LTLea Tuzovic
Lea Tuzovic
AMAshley Mills
Ashley Mills
WCWendy K. Chung
Wendy K. Chung
KAKwame Anyane-Yeboa
Kwame Anyane-Yeboa
STSha Tang
Sha Tang
DSDruckerei Stückle
Druckerei Stückle

13 July 2026 in Fetal Diagnosis and Therapy
Verified
Journal Article
Closed access
MTMariam Taleb
Mariam Taleb
JMJena L Miller
Jena L Miller
MAMeredith A. Atkinson
Meredith A. Atkinson
ABAhmet Alexander Baschat
Ahmet Alexander Baschat
MRMara Rosner
Mara Rosner
AMAnita J. Moon-Grady
Anita J. Moon-Grady
Introduction: Pulmonary hypoplasia and severe pulmonary hypertension associated with severe oligo/anhydramnios may be mitigated by amnioinfusion in fetal bilateral renal agenesis (BRA). We report fetal cardiovascular testing in live-born BRA subjects of the Renal Anhydramnios Fetal Therapy (RAFT) trial. Methods: Fetuses in the BRA RAFT trial cohort underwent third trimester echocardiography with maternal hyperoxia (MH). Echocardiographic parameters, compared between baseline and MH, are presented for expectant management and amnioinfusion participants using descriptive and inferential statistics. Results: Of 20 BRA pregnancies, 17 had amnioinfusions and 3 expectant management; 13 had fetal echocardiograms. Middle cerebral artery pulsatility index (PI) increased with MH (1.82 vs. 2.12, p = 0.032), as did umbilical artery PI (0.89 vs. 1.02, p = 0.056), without change in cardiac output or right ventricular percentage of the output, as expected. Fetuses in the intervention arm showed significant decrease in pulmonary artery PI compared to no decrease or an increase in the control arm. All fetuses with clear reactivity had favorable respiratory status at 30 days of life. Minimal reactivity (<10%) was not predictive of poor outcome. Pulmonary artery branch dimensions were significantly larger in the treated fetuses. Conclusion: Fetal echocardiography with MH provides antenatal evidence of rescued pulmonary phenotype in BRA fetuses undergoing serial percutaneous amnioinfusions.